Amphastar Pharmaceuticals (AMPH) Debt Ratio (2013 - 2026)

Amphastar Pharmaceuticals has reported Debt Ratio for 14 years, with the latest figure at 0.35 in Q2 2026.

• On a quarterly basis, Debt Ratio fell 6.85% year-over-year to 0.35 in Q2 2026; TTM through Jun 2026 was 0.35, a 6.85% decrease from a year earlier, with the FY2025 full-year figure at 0.37, down 1.81% from the prior year.
• Debt Ratio was 0.35 for Q2 2026 at Amphastar Pharmaceuticals, down from 0.37 in the prior quarter.
• The five-year high for Debt Ratio was 0.41 in Q3 2023, with the low at 0.1 in Q1 2023.
• Average Debt Ratio over 5 years is 0.3, with a median of 0.37 recorded in 2025.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio declined 12.76% in 2022, then soared 296.95% in 2023.
• Over 5 years, Debt Ratio stood at 0.1 in 2022, then jumped by 281.32% to 0.39 in 2023, then declined by 2.17% to 0.38 in 2024, then declined by 1.81% to 0.37 in 2025, then slipped by 6.31% to 0.35 in 2026.
• The last three Debt Ratio figures came in at 0.35 (Q2 2026), 0.37 (Q1 2026), and 0.37 (Q4 2025), per Business Quant data.